Board member

Constance Schultsz has been named WP 3 and 6 Co-leader and member of Executive Board

Tuesday 19 Jan 16
|
The General Assembly has approved of Constance Schultsz’s (AMC 13) membership to the Executive Board representing WP 3/6 as Co-leader.

As stated in the Consortium Agreement (6.3.1.2), the General Assembly must vote on the appointment of Executive Board members, and since the WP Leaders and Co-leaders are Executive Board members, the General Assembly must approve of any replacement.

The Coordinator and Co-Coordinator were notified by Menno de Jong (AMC 13) that due to work commitments, he will not be able to devote as much time to COMPARE as needed by a WP Co-leader. He will still participate in the project.

Constance Schultsz (AMC 13), is a medical microbiologist at the Academic Medical Center (AMC) of the University of Amsterdam (UvA) since 2008, and deputy head of the Department of Global Health. From 2003- 2008 she headed the Microbiology department at the Oxford University Clinical Research Unit, Vietnam in Ho Chi Minh City, Vietnam, where she still holds a Faculty position. Her research interests include antimicrobial drug resistance, nosocomial infections, and emerging infectious diseases.

Constance supervises PhD students in the Netherlands, Vietnam, Indonesia, and Nigeria. She has received research grants from the Dutch government as well as from the EU.

https://www.compare-europe.eu/news/nyhed?id=2eab0a60-a721-4ee9-afe0-49c7b33e0bdf
3 MAY 2024